reply to my questions part 27) Why has no or very little effort been made to promote the stock in la Belle Province?
I tend to disagree:
· We were in La Presse and Le Soleil last month· We were invited to present at Caisse de dépôt et de placement du Québec conference in Quebec City· We will be attending and presenting at BioContact in October· We continually have marketing days in Montreal to meet with institutions
8) What is being done in terms of promotion of the company?
· We recently completed a corporate video which has been distributed to all our contacts and was viewed my many at BIO International in Chicago. We will continue to use this video at the conferences we attend this year.· We have attended multiple conferences this year including WHO and BIO… currently our team is preparing for the World Vaccine Congress Asia which will be held next week· We contacted a reporter at Dow Jones newswire who wrote a piece on us that was picked up by many news outlets· We continue to actively talk to the investment community across North America and in addition completed some marketing days in Europe
9) Warrants (over $8,000,000 worth) are expiring at the end of November. To be worth it, they will have to be exercised around $1.25. It will be disastrous for the company, if they cannot be exercised. What will be done? Hoping for the best, extending the expiration date....?
We are well aware of the warrants that are outstanding. We look at all options on a capital markets perspective and continually reassess what options are best for the Company.
10) What is the percentage of shares in the hands of funds and companies, insiders, and private investors?
PMI 38.2%
Avenir Luzerne (Credit Agricole) 4.1%
Management & BOD 3.1%
I have been investing in juniors for the past thirty years. In the process, I have made and lost fortunes. Medicago is one of the most solid companies I have encountered in terms of potential, management, research, projects and innovation. One of the most important element for success on the stock market is to keep a company in the news and to keep investors informed no matter how trivial “the news” may be. Better to receive little news than no news.
Yes, we agree. We ensure to disclose all material events. The milestones that we will be reaching in 2010 will be released once they occur so please stay tuned.
For your information, of the nine companies who have joined the Toronto Stock Exchange in May, shares of six of them are up, one has remained the same and two are down. Unfortunately, Medigcago is one of the two and is down by the largest margin, representing almost 25%.
Please remember that we have no control over the short-term fluctuations in the share price. We can only control the long-term through building value within the Company and this is exactly what we are doing. We were a preclinical company last year, now we have a validated technology with our goal being to be a phase II company by the end of the year.
I am the first to admit that investing in a junior is a certain form of gambling. In this case, the odds, considering all the positives regarding Medicago, are on the company’s side. Let play it right.
Yours truly,
Dr. J………